AYGESTIN Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Aygestin, and what generic alternatives are available?
Aygestin is a drug marketed by Duramed Res and is included in one NDA.
The generic ingredient in AYGESTIN is norethindrone acetate. There are twenty-six drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the norethindrone acetate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Aygestin
A generic version of AYGESTIN was approved as norethindrone acetate by BARR on May 25th, 2001.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for AYGESTIN?
- What are the global sales for AYGESTIN?
- What is Average Wholesale Price for AYGESTIN?
Summary for AYGESTIN
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 62 |
| Clinical Trials: | 5 |
| Patent Applications: | 3,861 |
| DailyMed Link: | AYGESTIN at DailyMed |
Recent Clinical Trials for AYGESTIN
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Norton Healthcare | N/A |
| Scott and White Hospital & Clinic | Phase 4 |
| Boston Children's Hospital | Phase 2 |
US Patents and Regulatory Information for AYGESTIN
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Duramed Res | AYGESTIN | norethindrone acetate | TABLET;ORAL | 018405-001 | Apr 21, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
